Table 3 Tumor types in 747 women or men patients
Type | Number (%) | ||
|---|---|---|---|
Men (N = 503) | Women (N = 244) | Total (N = 747) | |
Lung cancer | 119 (23.7%) | 32 (13.1%) | 151 (20.2%) |
Colorectal cancer | 86 (17.1%) | 41 (16.8%) | 127 (17%) |
Esophagus cancer | 52 (10.3%) | 21 (8.6%) | 73 (9.8%) |
Liver cancer | 55 (10.9%) | 10 (4.1%) | 65 (8.7%) |
Nasopharynx cancer | 31 (6.2%) | 8 (3.3%) | 39 (5.2%) |
Pituitary tumor | 15 (3%) | 20 (8.2%) | 35 (4.7%) |
Stomach cancer | 21 (4.2%) | 11 (4.5%) | 32 (4.3%) |
Breast cancer | / | 28 (11.5%) | 28 (3.7%) |
Neurologic tumor | 16 (3.2%) | 11 (4.5%) | 27 (3.6%) |
Prostatic cancer | 24 (4.8%) | / | 24 (3.2%) |
Hematological malignancies | 14 (2.8%) | 9 (3.7%) | 23 (3.1%) |
Cervical cancer | / | 20 (8.2%) | 20 (2.7%) |
Bladder cancer | 16 (3.2%) | 1 (0.4%) | 17 (2.3%) |
Thyroid cancer | 3 (0.6%) | 8 (3.3%) | 11 (1.5%) |
Renal cancer | 6 (1.2%) | 1 (0.4%) | 7 (0.9%) |
Laryngocarcinoma | 6 (1.2%) | / | 6 (0.8%) |
Ovarian cancer | / | 6 (2.5%) | 6 (0.8%) |
Gastrointestinal stromal tumor | 3 (0.6%) | 2 (0.8%) | 5 (0.7%) |
Pancreatic cancer | 3 (0.6%) | 2 (0.8%) | 5 (0.7%) |
Thymic carcinoma | 2 (0.4%) | 2 (0.8%) | 4 (0.5%) |
Adrenal tumor | 3 (0.6%) | / | 3 (0.4%) |
Endometrial cancer | / | 3 (1.2%) | 3 (0.4%) |
More than two cancers | 22 (10.9%) | 4 (1.6%) | 26 (3.5%) |
Others | 6 (1.2%) | 4 (1.6%) | 10 (1.3%) |